The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs

References

• Agrahari V, Mitra AK. Therapeutic delivery. Ther. Deliv. 7(2), 117–138 (2016).
   PubMedGoogle Scholar
• Lee B-S, Yoon CW, Osipov A et al. Nanoprodrugs of NSAIDs: preparation and characterization of flufenamic acid nanoprodrugs. J. Drug Deliv. 2011, 1–13 (2011).
   Google Scholar
• Passi M, Shahid S, Chockalingam S, Sundar IK, Packirisamy G. Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: Implications for chronic airway diseases. Int. J. Nanomed. 15, 3803–3826 (2020).
   PubMed Web of Science ®Google Scholar
• Fatima R, Sharma M, Prasher P et al. Diversity of rationally modified polysaccharides for pharmaceutical applications. Chem. Select 8(20), Article e202300941 (2023).
   Google Scholar
• Banks SR, Enck K, Wright M, Opara EC, Welker ME. Chemical modification of alginate for controlled oral drug delivery. J. Agric. Food Chem. 67(37), 10481–10488 (2019).
   PubMed Web of Science ®Google Scholar
• Li L, Lei D, Zhang J et al. Dual-responsive alginate hydrogel constructed by sulfhdryl dendrimer as an intelligent system for drug delivery. Molecules 27(1), 1–13 (2022).
   Web of Science ®Google Scholar
• Eltaweil AS, Ahmed MS, El-Subruiti GM, Khalifa RE, Omer AM. Efficient loading and delivery of ciprofloxacin by smart alginate/carboxylated graphene oxide/aminated chitosan composite microbeads: in vitro release and kinetic studies. Arab. J. Chem. 16(4), 104533 (2023).
   Web of Science ®Google Scholar
• Singh B, Sharma V, Mohan M, Rohit, Sharma P, Ram K. Design of ciprofloxacin impregnated dietary fiber psyllium-moringa gum-alginate network hydrogels via green approach for use in gastro-retentive drug delivery system. Bioact. Carbohydr. Diet. Fibre 29, 100345 (2023).
   Google Scholar
• Long T, Tan W, Tian X et al. Gelatin/alginate-based microspheres with sphere-in-capsule structure for spatiotemporal manipulative drug release in gastrointestinal tract. Int. J. Biol. Macromol. 226, 485–495 (2023).
   PubMed Web of Science ®Google Scholar
• Ab'lah N, Yusuf CYL, Rojsitthisak P, Wong TW. Reinvention of starch for oral drug delivery system design. Int. J. Biol. Macromol. 241, 124506 (2023).
   PubMed Web of Science ®Google Scholar
• Prasher P, Fatima R, Sharma M. Therapeutic delivery with V-amylose. Drug Dev. Res. 82(6), 727–729 (2021).
   PubMed Web of Science ®Google Scholar
• Dadkhah Tehrani A, Parsamanesh M. Preparation, characterization and drug delivery study of a novel nanobiopolymeric multidrug delivery system. Mater. Sci. Eng. C. 73, 516–524 (2017).
   PubMed Web of Science ®Google Scholar
• Nouri A, Khoee S. Preparation of amylose-poly(methyl methacrylate) inclusion complex as a smart nanocarrier with switchable surface hydrophilicity. Carbohydr. Polym. 246(5), 116662 (2020).
   PubMedGoogle Scholar
• Prasher P, Sharma M, Singh SP. Drug encapsulating polysaccharide-loaded metal nanoparticles: a perspective drug delivery system. Drug Dev. Res. 82(2), 145–148 (2021).
   PubMed Web of Science ®Google Scholar
• Masina N, Choonara YE, Kumar P et al. A review of the chemical modification techniques of starch. Carbohydr. Polym. 157, 1226–1236 (2017).
   PubMed Web of Science ®Google Scholar
• Mahmoudi Najafi SH, Baghaie M, Ashori A. Preparation and characterization of acetylated starch nanoparticles as drug carrier: ciprofloxacin as a model. Int. J. Biol. Macromol. 87, 48–54 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou D, Liu S, Song H, Liu X, Tang X. Preparation and characterization of chemically modified high amylose maize starch-ascorbyl palmitate inclusion complexes in mild reaction condition. LWT 142, 110983 (2021).
   Web of Science ®Google Scholar
• Yu D, Xiao S, Tong C, Chen L, Liu X. Dialdehyde starch nanoparticles: preparation and application in drug carrier. Chinese Sci. Bull 52(21), 2913–2918 (2007).
   Google Scholar
• Carlson TL, Lock JY, Carrier RL. Engineering the mucus barrier. Annu. Rev. Biomed. Eng. 20, 197–220 (2018).
   PubMed Web of Science ®Google Scholar
• Cone RA. Barrier properties of mucus. Adv. Drug Deliv. Rev. 61(2), 75–85 (2009).
   PubMed Web of Science ®Google Scholar
• Prasher P, Fatima R, Sharma M. Cationic polysaccharides: emerging drug delivery vehicle across the physiological mucus barrier. Future Med. Chem. 14(8), 531–533 (2022).
   PubMed Web of Science ®Google Scholar
• Nouri A, Jelkmann M, Khoee S, Bernkop-Schnürch A. Diaminated starch: a competitor of chitosan with highly mucoadhesive properties due to increased local cationic charge density. Biomacromolecules 21(2), 999–1008 (2020).
   PubMed Web of Science ®Google Scholar
• Jelkmann M, Leichner C, Menzel C, Kreb V, Bernkop-Schnürch A. Cationic starch derivatives as mucoadhesive and soluble excipients in drug delivery. Int. J. Pharm. 570(9), 118664 (2019).
   PubMedGoogle Scholar
• Luo P, Liu L, Xu W, Fan L, Nie M. Preparation and characterization of aminated hyaluronic acid/oxidized hydroxyethyl cellulose hydrogel. Carbohydr. Polym. 199(2), 170–177 (2018).
   PubMedGoogle Scholar
• Nadanaciva S, Aleo MD, Strock CJ, Stedman DB, Wang H, Will Y. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Toxicol. Appl. Pharmacol. 272(2), 272–280 (2013).
   PubMed Web of Science ®Google Scholar
• Beck PL, Xavier R, Lu N et al. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 119(3), 699–705 (2000).
   PubMed Web of Science ®Google Scholar
• Prasher P, Sharma M. Medicinal chemistry of anthranilic acid derivatives: a mini review. Drug Dev. Res. 82(7), 945–958 (2021).
   PubMed Web of Science ®Google Scholar
• Whitehouse M. Drugs to treat inflammation: a historical overview. Front. Med. Chem. 4, 707–729 (2012).
   Google Scholar
• Oktaviyanti IK, Thalib I, Suhartono E. The protective efficacy of quercetin on mefenamic acid-induced gastric mucosal damage. Int. J. Pharm. Clin. Res. 8(10), 1390–1395 (2016).
   Google Scholar
• Rainsford K, Stetsko P. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory. J. Pharm. Pharmacol. 55(5), 661–668 (2003).
   PubMed Web of Science ®Google Scholar
• Lee W, Mun Y, Lee K-Y et al. Mefenamic acid-upregulated Nrf2/SQSTM1 protects hepatocytes against oxidative stress-induced cell damage. Toxics 11(9), 735 (2023).
   PubMed Web of Science ®Google Scholar
• Daniels MJD, Rivers-Auty J, Schilling T et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. Nat. Commun. 7, 24–30 (2016).
   Web of Science ®Google Scholar
• Khansari PS, Halliwell RF. Mechanisms underlying neuroprotection by the NSAID mefenamic acid in an experimental model of stroke. Front. Neurosci. 13(2), 1–10 (2019).
   PubMedGoogle Scholar
• Chiou SK, Mandayam S. NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis. Biochem. Pharmacol. 74(10), 1485–1495 (2007).
   PubMed Web of Science ®Google Scholar
• Kim KM, Song JJ, An JY, Kwon YT, Lee YJ. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. J. Biol. Chem. 280(49), 41047–41056 (2005).
   PubMed Web of Science ®Google Scholar
• Redlak MJ, Power JJ, Miller TA. Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells. Am. J. Physiol. – Gastrointest. Liver Physiol. 289(4), 731–738 (2005).
   Web of Science ®Google Scholar
• Pyrko P, Soriano N, Kardosh A et al. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol. Cancer 5, 1–16 (2006).
   PubMed Web of Science ®Google Scholar
• Mehihi AAR, Kubba AAR, Shihab WA, Tahtamouni LH. New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment. Med. Chem. Res. 32(11), 2334–2348 (2023).
   Web of Science ®Google Scholar
• Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl Acad. Sci. USA 96(13), 7563–7568 (1999).
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Macpherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104(6), 1832–1847 (1993).
   PubMed Web of Science ®Google Scholar
• Kankaanranta H, Moilanen E. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes. Mol. Pharmacol. 47(5), 1006–1013 (1995).
   PubMed Web of Science ®Google Scholar
• Paik JH, Ju JH, Lee JY, Boudreau MD, Hwang DH. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase: mediation through different signaling pathways. J. Biol. Chem. 275(36), 28173–28179 (2000).
   PubMed Web of Science ®Google Scholar
• Musumba C, Pritchard DM, Pirmohamed M. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment. Pharmacol. Ther. 30(6), 517–531 (2009).
   PubMed Web of Science ®Google Scholar
• Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem. Pharmacol. 180, 114147 (2020).
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 154(3), 500–514 (2018).
   PubMed Web of Science ®Google Scholar
• Rondeau-Mouro C, Le Bail P, Buléon A. Structural investigation of amylose complexes with small ligands: Inter- or intra-helical associations? Int. J. Biol. Macromol. 34(5), 251–257 (2004).
   Web of Science ®Google Scholar
• Le Bail P, Rondeau C, Buléon A. Structural investigation of amylose complexes with small ligands: helical conformation, crystalline structure and thermostability. Int. J. Biol. Macromol. 35(1–2), 1–7 (2005).
   PubMed Web of Science ®Google Scholar
• Prasher P, Fatima R, Sharma M. Therapeutic delivery with V-amylose. Drug Dev. Res. 82(6), 727–729 (2021).
   PubMed Web of Science ®Google Scholar
• Ab'lah N, Yusuf CYL, Rojsitthisak P, Wong TW. Reinvention of starch for oral drug delivery system design. Int. J. Biol. Macromol. 241, 124506 (2023).
   PubMed Web of Science ®Google Scholar
• Tester RF, Karkalas J, Qi X. Starch – composition, fine structure and architecture. J. Cereal Sci. 39(2), 151–165 (2004).
   Web of Science ®Google Scholar
• Tan L, Kong L. Starch-guest inclusion complexes: formation, structure, and enzymatic digestion. Crit. Rev. Food Sci. Nutr. 60(5), 780–790 (2020).
   PubMed Web of Science ®Google Scholar
• Phuong Ta L, Bujna E, Kun S, Charalampopoulos D, Khutoryanskiy VV. Electrosprayed mucoadhesive alginate-chitosan microcapsules for gastrointestinal delivery of probiotics. Int. J. Pharm. 597(2), (2021).
   Google Scholar
• Obiro WC, Sinha Ray S, Emmambux MN. V-amylose structural characteristics, methods of preparation, significance, and potential applications. Food Rev. Int. 28(4), 412–438 (2012).
   Google Scholar
• Lamberts L, Gomand SV, Derycke V, Delcour JA. Presence of amylose crystallites in parboiled rice. J. Agric. Food Chem. 57(8), 3210–3216 (2009).
   PubMed Web of Science ®Google Scholar
• Karkalas J, Ma S, Morrison WR, Pethrick RA. Some factors determining the thermal properties of amylose inclusion complexes with fatty acids. Carbohydr. Res. 268(2), 233–247 (1995).
   Web of Science ®Google Scholar
• Kwaśniewska-Karolak I, Nebesny E, Rosicka-Kaczmarek J. Characterization of amylose-lipid complexes derived from different wheat varieties and their susceptibility to enzymatic hydrolysis. Food Sci. Technol. Int. 14(1), 29–37 (2008).
   Web of Science ®Google Scholar
• Nebesny E, Kwaśniewska-Karolak I, Rosicka-Kaczmarek J. Dependence of thermodynamic characteristics of amylose-lipid complex dissociation on a variety of wheat. Starch – Stärke 57(8), 378–383 (2005).
   Web of Science ®Google Scholar
• Godet MC, Bizot H, Buléon A. Crystallization of amylose-fatty acid complexes prepared with different amylose chain lengths. Carbohydr. Polym. 27(1), 47–52 (1995).
   Web of Science ®Google Scholar
• Gelders G, Vanderstukken T, Goesaert H, Delcour J. Amylose–lipid complexation: a new fractionation method. Carbohydr. Polym. 56(4), 447–458 (2004).
   Web of Science ®Google Scholar
• Derycke V, Vandeputte GE, Vermeylen R et al. Starch gelatinization and amylose-lipid interactions during rice parboiling investigated by temperature resolved wide angle x-ray scattering and differential scanning calorimetry. J. Cereal Sci. 42(3), 334–343 (2005).
   Web of Science ®Google Scholar
• Jovanovich G, Zamponi RA, Lupano CE, Anon MC. Effect of water content on the formation and dissociation of the amylose–lipid complex in wheat flour. J. Agric. Food Chem. 40(10), 1789–1793 (1992).
   Web of Science ®Google Scholar
• Tufvesson F, Eliasson A-C. Formation and crystallization of amylose–monoglyceride complex in a starch matrix. Carbohydr. Polym. 43(4), 359–365 (2000).
   Web of Science ®Google Scholar
• Heinemann C, Zinsli M, Renggli A, Escher F, Conde-Petit B. Influence of amylose-flavor complexation on build-up and breakdown of starch structures in aqueous food model systems. LWT – Food Sci. Technol. 38(8), 885–894 (2005).
   Web of Science ®Google Scholar
• Tufvesson F, Wahlgren M, Eliasson A. Formation of amylose-lipid complexes and effects of temperature treatment. Part 1. Monoglycerides. Starch – Stärke 55(2), 61–71 (2003).
   Web of Science ®Google Scholar
• Zabar S, Lesmes U, Katz I, Shimoni E, Bianco-Peled H. Studying different dimensions of amylose-long chain fatty acid complexes:molecular, nano and micro level characteristics. Food Hydrocoll. 23(7), 1918–1925 (2009).
   Web of Science ®Google Scholar
• TANG M, COPELAND L. Analysis of complexes between lipids and wheat starch. Carbohydr. Polym 67(1), 80–85 (2007).
   Web of Science ®Google Scholar
• Eliasson AC, Finstad H, Ljunger G. A Study of starch–lipid interactions for some native and modified maize starches. Starch – Stärke 40(3), 95–100 (1988).
   Web of Science ®Google Scholar
• Fanta G. Steam jet cooking of high-amylose starch-fatty acid mixtures. An investigation of complex formation. Carbohydr. Polym. 38(1), 1–6 (1999).
   Web of Science ®Google Scholar
• Biliaderis CG, Galloway G. Crystallization behavior of amylose-V complexes: structure–property relationships. Carbohydr. Res. 189(C), 31–48 (1989).
   Google Scholar
• Biliaderis CG, Page CM, Maurice TJ. Non-equilibrium melting of amylose-V complexes. Carbohydr. Polym. 6(4), 269–288 (1986).
   Web of Science ®Google Scholar
• Zhang L, Cheng H, Zheng C et al. Structural and release properties of amylose inclusion complexes with ibuprofen. J. Drug Deliv. Sci. Technol. 31, 101–107 (2016).
   Web of Science ®Google Scholar
• Yang L, Zhang B, Yi J, Liang J, Liu Y, Zhang LM. Preparation, characterization, and properties of amylose-ibuprofen inclusion complexes. Starch/Staerke 65(7–8), 593–602 (2013).
   Web of Science ®Google Scholar
• Cai X, Yang L, Zhang LM, Wu Q. Evaluation of amylose used as a drug delivery carrier. Carbohydr. Res. 345(7), 922–928 (2010).
   PubMed Web of Science ®Google Scholar
• Cohen R, Orlova Y, Kovalev M, Ungar Y, Shimoni E. Structural and functional properties of amylose complexes with genistein. J. Agric. Food Chem. 56(11), 4212–4218 (2008).
   PubMed Web of Science ®Google Scholar
• Rezvani M, Mohammadnejad J, Narmani A, Bidaki K. Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system. Int. J. Biol. Macromol. 113, 1287–1293 (2018).
   PubMed Web of Science ®Google Scholar
• Marinopoulou A, Christofilos D, Arvanitidis J, Raphaelides SN. Interaction of tretinoin and nimesulide with amylose matrices. Starch/Staerke 73(1–2), 1–15 (2021).
   Web of Science ®Google Scholar
• Carbinatto FM, Ribeiro TS, Colnago LA, Evangelista RC, Cury BSF. Preparation and characterization of amylose inclusion complexes for drug delivery applications. J. Pharm. Sci. 105(1), 231–241 (2016).
   PubMed Web of Science ®Google Scholar
• Galati G, Tafazoli S, Sabzevari O, Chan TS, O'Brien PJ. Idiosyncratic NSAID drug induced oxidative stress. Chem. Biol. Interact. 142(1–2), 25–41 (2002).
   PubMed Web of Science ®Google Scholar
• Siew LF, Man SM, Newton JM, Basit AW. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Int. J. Pharm. 273(1–2), 129–134 (2004).
   PubMedGoogle Scholar
• Milojevic S, Newton JM, Cummings JH et al. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Control Release 38(1), 75–84 (1996).
   Web of Science ®Google Scholar
• Ganje M, Jafari SM, Tamadon AM, Niakosari M, Maghsoudlou Y. Mathematical and fuzzy modeling of limonene release from amylose nanostructures and evaluation of its release kinetics. Food Hydrocoll. 95(4), 186–194 (2019).
   Google Scholar
• Fatima R, Sharma M, Prasher P. Targeted delivery of flufenamic acid by V-amylose. Ther. Deliv. 12(8), 575–582 (2021).
   PubMed Web of Science ®Google Scholar
• Prasher P, Fatima R, Sharma M. Resistant starch: ideal candidate for the enteric coating of NSAIDs? Future Med. Chem. 13(17), 1411–1414 (2021).
   PubMed Web of Science ®Google Scholar
• Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release. Int. J. Pharm. 583, 119379 (2020).
   PubMedGoogle Scholar
• Varum F, Freire AC, Bravo R, Basit AW. OPTICORE™, an innovative and accurate colonic targeting technology. Int. J. Pharm. 583, 119372 (2020).
   PubMedGoogle Scholar
• Guerra-Ponce WL, Gracia-Vásquez SL, González-Barranco P et al. In vitro evaluation of sustained released matrix tablets containing ibuprofen: a model poorly water-soluble drug. Brazilian J. Pharm. Sci. 52(4), 751–760 (2016).
   Web of Science ®Google Scholar
• De Brabander C, Vervaet C, Fiermans L, Remon JP. Matrix mini-tablets based on starch/microcrystalline wax mixtures. Int. J. Pharm. 199(2), 195–203 (2000).
   PubMedGoogle Scholar
• Desai KG. Properties of tableted high-amylose corn starch–pectin blend microparticles intended for controlled delivery of diclofenac sodium. J. Biomater. Appl. 21(3), 217–233 (2007).
   PubMed Web of Science ®Google Scholar
• Fatima R, Sharma M, Dhiman A, Arora A, Mudila H, Prasher P. Targeted delivery of fenamates with aminated starch. Ther. Deliv. 14(3), 183–192 (2023).
   PubMed Web of Science ®Google Scholar
• Vangijzegem T, Stanicki D, Laurent S. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin. Drug Deliv. 16(1), 69–78 (2019).
   PubMed Web of Science ®Google Scholar
• Dung TT, Danh TM, Hoa LTM, Chien DM, Duc NH. Structural and magnetic properties of starch-coated magnetite nanoparticles. J. Exp. Nanosci. 4(3), 259–267 (2009).
   Web of Science ®Google Scholar
• Aslam H, Shukrullah S, Naz MY et al. Current and future perspectives of multifunctional magnetic nanoparticles based controlled drug delivery systems. J. Drug Deliv. Sci. Technol. 67, 102946 (2022).
   Web of Science ®Google Scholar
• Munjeri O, Collett JH, Fell JT. Amidated pectin hydrogel beads for colonic drug delivery – an in vitro study. Drug Deliv. J. Deliv. Target. Ther. Agents 4(3), 207–211 (1997).
   Google Scholar
• Okonogi S, Khongkhunthian S, Jaturasitha S. Development of mucoadhesive buccal films from rice for pharmaceutical delivery systems. Drug Discov. Ther. 8(6), 262–267 (2014).
   PubMedGoogle Scholar
• Devi M, Sharma M. Statistical optimization of compression coated ketoprofen tablet using amylose/ethyl cellulose mixture for colonic delivery. J. Appl. Pharm. Res. 2348, 10–17 (2015).
   Google Scholar
• Cai X, Yang L, Zhang L-M, Wu Q. Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery. Bioresour. Technol. 100(18), 4164–4170 (2009).
   PubMed Web of Science ®Google Scholar
• Freire C, Podczeck F, Ferreira D, Veiga F, Sousa J, Pena A. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. J. Pharm. Pharmacol. 62(1), 55–61 (2010).
   PubMed Web of Science ®Google Scholar
• Le CAK, Ogawa Y, Dubreuil F et al. Crystal and molecular structure of V-amylose complexed with ibuprofen. Carbohydr. Polym. 261(12), Article 117885 (2021).
   PubMedGoogle Scholar
• Benyerbah N, Ispas-Szabo P, Sakeer K, Chapdelaine D, Mateescu MA. Ampholytic and polyelectrolytic starch as matrices for controlled drug delivery. Pharmaceutics 11(6), Article 253 (2019).
   PubMed Web of Science ®Google Scholar
• Parra AP, Martínez Ramírez JA, Mora Huertas CE. Preparation and characterization of native starch-ibuprofen molecular inclusion complexes. J. Drug Deliv. Sci. Technol. 63(4), 102509 (2021).
   Google Scholar
• Tuleu C, Basit AW, Waddington WA, Ell PJ, Newton JM. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules. Aliment. Pharmacol. Ther. 16(10), 1771–1779 (2002).
   PubMed Web of Science ®Google Scholar
• Soares GA, De Castro AD, Cury BSF, Evangelista RC. Blends of cross-linked high amylose starch/pectin loaded with diclofenac. Carbohydr. Polym. 91(1), 135–142 (2013).
   PubMed Web of Science ®Google Scholar
• Bisharat L, Barker SA, Narbad A, Craig DQM. In vitro drug release from acetylated high amylose starch-zein films for oral colon-specific drug delivery. Int. J. Pharm. 556, 311–319 (2019).
   PubMedGoogle Scholar
• Meneguin AB, Ferreira Cury BS, dos Santos AM, Franco DF, Barud HS, da Silva Filho EC. Resistant starch/pectin free-standing films reinforced with nanocellulose intended for colonic methotrexate release. Carbohydr. Polym. 157, 1013–1023 (2017).
   PubMed Web of Science ®Google Scholar
• Kshirsagar SJ, Bhalekar MR, Shewale NS, Godbole VP, Jagdale PK, Mohapatra SK. Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: optimization by factorial design. Drug Deliv. 18(6), 385–393 (2011).
   PubMed Web of Science ®Google Scholar
• Baek HH, Kim DH, Kwon SY et al. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose. Arch. Pharm. Res. 35(4), 683–689 (2012).
   PubMed Web of Science ®Google Scholar
• Trenfield SJ, Awad A, McCoubrey LE et al. Advancing pharmacy and healthcare with virtual digital technologies. Adv. Drug Deliv. Rev. 182, 114098 (2022).
   PubMed Web of Science ®Google Scholar
• Styliari ID, Taresco V, Theophilus A, Alexander C, Garnett M, Laughton C. Nanoformulation-by-design: an experimental and molecular dynamics study for polymer coated drug nanoparticles. RSC Adv. 10(33), 19521–19533 (2020).
   PubMed Web of Science ®Google Scholar
• Salma H, Melha YM, Sonia L, Hamza H, Salim N. Efficient prediction of in vitro piroxicam release and diffusion from topical films based on biopolymers using deep learning models and generative adversarial networks. J. Pharm. Sci. 110(6), 2531–2543 (2021).
   PubMed Web of Science ®Google Scholar
• Yacoub AS, Ammar HO, Ibrahim M, Mansour SM, El Hoffy NM. Artificial intelligence-assisted development of in situ forming nanoparticles for arthritis therapy via intra-articular delivery. Drug Deliv. 29(1), 1423–1436 (2022).
   PubMed Web of Science ®Google Scholar
• McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S, Basit AW. Colonic drug delivery: formulating the next generation of colon-targeted therapeutics. J. Control. Release 353, 1107–1126 (2023).
   PubMed Web of Science ®Google Scholar
• Yan C, Kim S-R. Microencapsulation for pharmaceutical applications: a review. ACS Appl. Bio. Mater. 7(2), 692–710 (2024).
   PubMedGoogle Scholar